Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2013

Jan 4, 2013

32853_dirs_2013-01-04_6b80e807-07f1-44f0-8074-5d3b2449a871.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-01-02

Reporting Person: JONES ROBERT C (EVP, RESEARCH & DEVELOPMENT)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-01-02 Common Stock M 4483 $4.0828 Acquired 4483 Direct
2013-01-02 Common Stock M 1220 $4.4461 Acquired 5703 Direct
2013-01-02 Common Stock S 5703 $14.44 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-01-02 Employee Stock Option (Right to Buy) $4.0828 M 4483 Disposed 2019-11-17 Common Stock (4483) Direct
2013-01-02 Employee Stock Option (Right to Buy) $4.4461 M 1220 Disposed 2018-04-23 Common Stock (1220) Direct

Footnotes

F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2012.

F2: 61% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 39% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining 39% of the shares subject to the Option shall vest each month thereafter such that all shares subject to the Option shall be fully vested on April 1, 2013.

F3: The shares subject to the Option fully vested on March 22, 2010.